The Camlee Group Advise on the Sale of Agenda1 Analytical Services Limited to Concept Life Sciences Limited
The Camlee Group acted as lead advisors in a deal which was brought to a successful conclusion on Thursday 15th October 2015, to the delight of vendors Ian Siragher, Simon Bristow, Caroline German and Madge Hollowood.
Manchester, United Kingdom, October 22, 2015 --(PR.com)-- Established in 2006, Agenda1 Analytical Services Ltd provides specialist contract analytical services, primarily to the pharmaceutical and medical device sectors. The business has experienced steady and consistent growth since inception and thanks to its burgeoning reputation, it will enjoy further growth over the foreseeable future.
Concept Life Sciences, supported by Equistone Partners Europe, is an international scientific laboratory and consultancy business, which has made several acquisitions with a combined enterprise value of over $100 million. The acquisition of Agenda1 Analytical Services comes hot on the heels of Concept Life Science’s acquisition of CXR Biosciences.
Paul Thompson, Project Director at The Camlee Group, said, “We are extremely happy to have concluded this deal on behalf of our clients. In keeping with the level of activity this sector has seen over recent months, we experienced a high level of interest in this opportunity. Concept have been very active over the last 18 months and acted swiftly in firming up their initial interest and ultimately delivering a deal that was acceptable to our clients. We are sure that Agenda1 will continue to grow and flourish as part of the wider Concept Group”.
Ian Siragher, Managing Director of Agenda1 explained that Camlee played a pivotal role in bringing this deal to completion, “Camlee took an active and hands on role in the management of this process right from the beginning. Paul has remained focused and proactive throughout and has taken ownership of key issues without hesitation. The experience and technical expertise was particularly helpful and Paul assisted in keeping us on track to completion by remaining objective up to finalising the deal.”
Concept Life Sciences CEO Alan Morgan said, “Agenda1 has a very strong business model merging significant capability and skilled staff with a positive reputation. By combining innovative and unrestricted thinking they have successfully created a problem-solving flexibility that is invaluable to its customers. This approach is complementary to Concept Life Sciences’ established business base.”
About the Camlee Group
The Camlee Group is a corporate finance boutique based in Sale, South Manchester, offering a progressive, fresh-thinking approach to the sale of profitable owner-managed UK businesses. The company prides itself on its industry leading expertise and in offering strategic, customised solutions in all areas of cross border transactions across a broad range of sectors.
Press contact
Ruth Morley
+44 (0)161 870 1560
ruthm@camleegroup.com
Concept Life Sciences, supported by Equistone Partners Europe, is an international scientific laboratory and consultancy business, which has made several acquisitions with a combined enterprise value of over $100 million. The acquisition of Agenda1 Analytical Services comes hot on the heels of Concept Life Science’s acquisition of CXR Biosciences.
Paul Thompson, Project Director at The Camlee Group, said, “We are extremely happy to have concluded this deal on behalf of our clients. In keeping with the level of activity this sector has seen over recent months, we experienced a high level of interest in this opportunity. Concept have been very active over the last 18 months and acted swiftly in firming up their initial interest and ultimately delivering a deal that was acceptable to our clients. We are sure that Agenda1 will continue to grow and flourish as part of the wider Concept Group”.
Ian Siragher, Managing Director of Agenda1 explained that Camlee played a pivotal role in bringing this deal to completion, “Camlee took an active and hands on role in the management of this process right from the beginning. Paul has remained focused and proactive throughout and has taken ownership of key issues without hesitation. The experience and technical expertise was particularly helpful and Paul assisted in keeping us on track to completion by remaining objective up to finalising the deal.”
Concept Life Sciences CEO Alan Morgan said, “Agenda1 has a very strong business model merging significant capability and skilled staff with a positive reputation. By combining innovative and unrestricted thinking they have successfully created a problem-solving flexibility that is invaluable to its customers. This approach is complementary to Concept Life Sciences’ established business base.”
About the Camlee Group
The Camlee Group is a corporate finance boutique based in Sale, South Manchester, offering a progressive, fresh-thinking approach to the sale of profitable owner-managed UK businesses. The company prides itself on its industry leading expertise and in offering strategic, customised solutions in all areas of cross border transactions across a broad range of sectors.
Press contact
Ruth Morley
+44 (0)161 870 1560
ruthm@camleegroup.com
Contact
The Camlee Group
Ruth Syddall
01618701555
www.camleegroup.com
Contact
Ruth Syddall
01618701555
www.camleegroup.com
Categories